Saba Ilac Sanayive Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SABA ILAC SANAYIVE, and what generic and branded alternatives to SABA ILAC SANAYIVE drugs are available?
SABA ILAC SANAYIVE has one approved drug.
Summary for Saba Ilac Sanayive
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Saba Ilac Sanayive
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Saba Ilac Sanayive | FUROSEMIDE | furosemide | INJECTABLE;INJECTION | 215856-001 | Apr 2, 2024 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
